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Purpose: To evaluate the diagnostic performance of gray-scale ul-
trasonography (US) and elastography in differentiating 
benign and malignant thyroid nodules.
Materials and 
Methods:
This was an institutional review board–approved retro-
spective study with waiver of informed consent. A total 
of 703 solid thyroid nodules in 676 patients (mean age, 
49.7 years; range, 18–79 years) were included; there were 
556 women (mean age, 49.5 years; range, 20–74 years) 
and 120 men (mean age, 50.7 years; range, 18–79 years). 
Nodules with marked hypoechogenicity, poorly defined 
margins, microcalcifications, and a taller-than-wide shape 
were classified as suspicious at grayscale US. Findings at 
elastography were classified according to the Rago crite-
ria and the Asteria criteria. The diagnostic performances 
of gray-scale US and elastography were compared. For 
comparison between the diagnostic performances of gray-
scale US and the combination of gray-scale US and elas-
tography, three sets of criteria were assigned: criteria set 
1, nodules with any suspicious grayscale US feature were 
assessed as suspicious; criteria set 2, Rago criteria were 
added as suspicious features to criteria set 1; and criteria 
set 3, Asteria criteria were added as suspicious features 
to criteria set 1. The diagnostic performances of gray-
scale US, elastography with Rago criteria, and elastogra-
phy with Asteria criteria, and odds ratios (ORs) with 95% 
confidence intervals for predicting thyroid malignancy 
were compared using generalized estimating equation 
analysis.
Results: Of 703 nodules, 217 were malignant and 486 were benign. 
Sensitivity, negative predictive value (NPV), and OR of 
gray-scale US for the 703 nodules were 91.7%, 94.7%, 
and 22.1, respectively, and these values were higher than 
the 15.7% and 65.4% sensitivity, 71.7% and 79.1% NPV, 
and 3.7 and 2.6 ORs found for elastography with Rago 
and Asteria criteria, respectively. Specificity, positive pre-
dictive value, and accuracy for criteria set 1 were signifi-
cantly higher than those for criteria sets 2 and 3 for most 
of the nodule subgroups that were considered.
Conclusion: Elastography alone, as well as the combination of elastog-
raphy and gray-scale US, showed inferior performance in 
the differentiation of malignant and benign thyroid nod-
ules compared with gray-scale US features; elastography 
was not a useful tool in recommending fine-needle aspi-
ration biopsy.
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nodules containing cystic components 
were excluded. Of 763 completely 
solid nodules, 60 were excluded for the 
following reasons: Elastography for 17 
nodules had not been performed suc-
cessfully because the nodules were bulg-
ing masses causing skin elevation (n = 
7) or the pressure indicator at elastog-
raphy displayed on the screen was 4 or 
more (n = 10). Forty-three nodules sus-
picious for papillary thyroid carcinoma 
(n = 3) or with indeterminate (n = 4) or 
inadequate results (n = 36) at cytologic 
evaluation were excluded because they 
had not undergone surgery or repeat 
US-guided FNA (Fig 1). Thyroid nod-
ules that met the following criteria were 
included: (a) benign or malignant re-
sults at cytologic evaluation, (b) thyroid 
surgery was performed after obtaining 
cytologic results suspicious for papillary 
thyroid carcinoma or indeterminate re-
sults, such as follicular or Hürthle cell 
neoplasm, or (c) benign or malignant 
results at follow-up US-guided FNA or 
thyroid surgery after cytologic results 
of inadequate specimen (Fig 1). Fi-
nally, 703 solid thyroid nodules in 676 
patients (mean age, 49.7 years; range, 
18–79 years) were included in this 
study; patients included 556 women 
(mean age, 49.5 years; range, 20–74 
years) and 120 men (mean age, 50.7 
years; range, 18–79 years). Of the 703 
performed to evaluate the diagnostic 
performance of elastography (2,3,9–
11,13–17), most were performed in 
small series (3,9–11,13–17). Moreover, 
although combinations of suspicious 
gray-scale US features, such as marked 
hypoechogenicity, microlobulated or 
irregular margins, microcalcifications, 
and a shape that is taller than wide, 
show higher diagnostic performances 
than each individual gray-scale US fea-
ture (18–24), elastography has been 
evaluated without comparison with 
gray-scale US (15), with each gray-scale 
US feature, or with combinations of a 
few suspicious gray-scale US features 
(2,3,9–11,13,14,16,17). To evaluate the 
diagnostic performance of elastogra-
phy either as an adjunctive diagnostic 
tool to gray-scale US or as a separate 
diagnostic tool, comparison between 
elastography and gray-scale US features 
that are widely used in clinical practice 
is necessary.
Therefore, our purpose was to eval-
uate the diagnostic performances of 
gray-scale US and elastography in dif-
ferentiating benign and malignant thy-
roid nodules.
Materials and Methods
The institutional review board approved 
this retrospective study and did not re-
quire patient approval or informed con-
sent for the review of patient images 
and records.
Patients
From June to November 2009, 864 thy-
roid nodules were imaged at gray-scale 
US, elastography, and US-guided fine-
needle aspiration (FNA). Of these, 101 
A firm and hard thyroid nodule on palpation is associated with an increased risk of malignancy 
(1). Palpation is subjective and highly 
dependent on the examiner and on the 
size and location of the nodules (2–4). 
Elastography has been introduced to 
evaluate the tissue hardness objec-
tively and to augment the diagnostic 
accuracy of gray-scale ultrasonography 
(US) (5,6). The stiffness of thyroid 
nodules is dependent on the composi-
tion and cellularity of the nodule (7). 
The basic concept of US elastography 
is that compression applied to the thy-
roid tissue produces the strain (tissue 
displacement in longitudinal direction) 
within the tissue, and the amount of 
strain is less in harder tissues than in 
softer ones (8). Elastography is useful 
in differentiating malignant from be-
nign thyroid nodules because malignant 
nodules are harder than the surround-
ing adjacent parenchyma (2,3,7,9–16). 
Although many studies have been 
Implication for Patient Care
 n Because elastography alone, as 
well as the combination of elas-
tography and gray-scale US, 
showed inferior performance in 
the differentiation of malignant 
and benign thyroid nodules in 
comparison with gray-scale US 
features, elastography was not a 
useful tool in recommending fine-
needle aspiration biopsy.
Advances in Knowledge
 n The sensitivity, specificity, posi-
tive predictive value (PPV), nega-
tive predictive value (NPV), and 
accuracy of gray-scale US alone 
were 91.7%, 66.7%, 55.1%, 
94.7%, and 74.4%, respectively; 
these values were superior to the 
15.7% and 65.4% sensitivity, 
95.3% and 58.2% specificity, 
59.6% and 41.2% PPV, 71.7% 
and 79.1% NPV, and 70.7% and 
60.5% accuracy of elastography 
with Rago and Asteria criteria, 
respectively.
 n The sensitivity, specificity, PPV, 
NPV, and accuracy for the combi-
nation of gray-scale US and elas-
tography with Rago (criteria set 
2) and Asteria (criteria set 3) 
criteria were 92.2% and 94.5%, 
65% and 47.5%, 54.1% and 
44.6%, 94.9% and 95.1%, and 
73.4% and 62%, respectively; 
these values were not superior to 
the 91.7%, 66.7%, 55.1%, 
94.7%, and 74.4%, respectively, 
of grayscale US alone (criteria 
set 1).
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hypoechogenicity, poorly defined mar-
gin, microcalcifications, and taller than 
wide shape (20,21). When thyroid nod-
ules showed one or more of these suspi-
cious malignant gray-scale US features, 
they were assessed as “suspicious” 
(20,21). When thyroid nodules showed 
no suspicious features, they were as-
sessed as “probably benign” (20,21).
Real-time Elastography
After gray-scale examination, elastog-
raphy was routinely performed by the 
same radiologists who performed gray-
scale US. Elastography was performed 
in thyroid nodules detected at gray-
scale US and targeted for US-guided 
FNA by using the same US machine and 
probe. Freehand technique was used 
in obtaining elastography images. All 
elastography images were obtained in 
longitudinal planes. Prior to performing 
elastography, each of the eight radiolo-
gists had 2 months of experience with 
the machine and weekly thyroid imag-
ing conferences regarding elastography 
images. During the training, each eight 
radiologist performed more than 205 
US-guided FNA procedures for thyroid 
nodules, and elastography for thyroid 
nodules was performed for more than 
100 nodules.
During elastography, the probe 
was positioned perpendicular to the 
skin while applying pressure. Images 
were obtained by applying light repeti-
tive compression at the skin above the 
targeted thyroid nodule. A square re-
gion of interest positioning the target 
nodule at the center of the box was 
set for elastography acquisition. The 
superior margin was set to include 
subcutaneous fat, and the inferior 
margin was set to include longus colli 
muscle. Radiologists obtained optimal 
images showing both color homoge-
neity within the region of interest and 
pressure indicator displayed on the 
screen ranging between 2 and 3. Im-
ages were displayed in a split-screen 
mode, with the gray-scale images on 
the right and the translucent color-
scale elastography images superim-
posed on the corresponding gray-scale 
US image in the left. Each pixel of the 
elasticity image was shown as one of 
who performed the US examination 
and FNA at our institution. The internal 
component of thyroid nodules which 
undergo US-guided FNA are routinely 
classified and recorded as completely 
solid, cystic portion greater than 50%, 
or cystic portion less than or equal to 
50% at our institution. Based on our 
database, only completely solid thyroid 
nodules were included. Echogenicity 
was classified as hyper-, iso-, or hy-
poechogenicity (when a nodule showed 
hyper-, iso-, or hypoechogenicity com-
pared with the normal thyroid gland) or 
marked hypoechogenicity (when a nod-
ule showed relatively hypoechogenicity 
compared with the surrounding strap 
muscle). Margin was classified as well 
defined or poorly defined (microlobu-
lated or irregular margin). Calcifica-
tions were classified as microcalcifica-
tions (less than or equal to 1 mm in 
diameter; tiny, punctate, hyperechoic 
foci, either with or without acoustic 
shadows), macrocalcification, eggshell 
calcification, or no calcification. Shape 
was classified as wider than tall or 
taller than wide. Suspicious malignant 
gray-scale US features included marked 
nodules, 308 were larger than 10 mm 
and 395 nodules were 10 mm or small-
er. There were 577 nodules larger than 
5 mm and 126 nodules 5 mm or smaller 
(Table 1). There were 114 nodules in 
112 patients that had macrocalcifica-
tions (n = 96) or eggshell calcifications 
(n = 18). Twenty-seven patients under-
went US-guided FNA for two thyroid 
nodules and 649 patients underwent 
US-guided FNA for one thyroid nodule. 
In 221 nodules in 202 patients, surgery 
was performed after FNA.
Real-time Gray-Scale US
All gray-scale US images were obtained 
by using a 6–14-MHz linear array trans-
ducer (EUB-7500; Hitachi Medical, To-
kyo, Japan). Real-time gray-scale US 
was performed by one of eight radiolo-
gists with 1 year to 15 years of experi-
ence in thyroid imaging.
Gray-scale US features of thyroid 
nodules that underwent US-guided FNA 
were prospectively recorded in the radi-
ology reports according to the internal 
component, echogenicity, margin, cal-
cifications, shape, and final assessment 
at the time of FNA by the radiologists 
Figure 1
Figure 1: Inclusion criteria for the study. FNA = thyroid nodules with repeat aspirations, Non-Op = thyroid 
nodules in which no surgery was performed, Op = thyroid nodules in which surgery was performed.
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malignancy (13). Elasticity according 
to Asteria et al (hereafter, Asteria cri-
teria) originated from the elastography 
by Ito et al (8) and was applied to thy-
roid nodules and elastography scores 
were classified on a scale of 1 to 4 (Fig 
3). Nodules with Asteria scores of 3 
and 4 were classified as suspicious 
(9). Elasticity according to Rago et al 
(hereafter, Rago criteria) originated 
from the elastography scale by Ueno 
et al (25) and was applied to thyroid 
nodules and elastography scores were 
classified on a scale of 1 to 5 (Fig 2
). Nodules with Rago scores of 4 and 
5 were classified as suspicious for 
the 256 specific colors, representing 
the extent of strain. The scale ranged 
from red, showing areas of great-
est strain (ie, softest component), 
to blue, showing no strain (ie, hard-
est component). Elastography images 
were classified according to the scores 
by Rago et al (13) and Asteria et al 
Table 1
Nodule Size and Numbers of Nodules and Patients
Parameter Nodules Patients
Final Diagnosis
Benign Malignant P Value*
All Nodules 703 676 486 217
 Mean nodule size (mm) 11.6 12.6 (3–51) 9.3 (2–38) ,.001
 Mean patient age (y) 48.9 (18–79) 50.9 (20–79) 47.3 (18–73) ,.001
 Women 579 556 399 180 .809
 Men 124 120 87 37
Nodules .10 mm 308 296 239 (77.6%) 69 (22.4%)
 Mean nodule size (mm) 17.9 18.6 (11–51) 15.4 (11–38) .006
 Mean patient age (y) 49.5 (18–75) 50.9 (20–75) 44.6 (18–70) ,.001
 Women 243 234 189 15 .917
 Men 65 62 50 54
Nodules 10 mm 395 380 247 (62.5%) 148 (37.5%)
 Mean nodule size (mm) 6.7 (2–10) 6.9 (3–10) 6.5 (2–10) .055
 Mean patient age (y) 50.0 (21–79) 50.8 (21–79) 48.6 (22–73) .055
 Women 336 210 126 .965
 Men 59 37 22
Nodules .5 mm 577 554 410 (71.1%) 167 (28.9%)
 Mean nodule size (mm) 13.2 (6–51) 14.2 (6–51) 10.8 (6–38) ,.001
 Mean patient age (y) 50.4 (18–79) 51.4 (20–79) 47.9 (18–73) .003
 Women 468 333 135 .939
 Men 109 77 32
Nodules 5 mm 126 122 76 (60.3%) 50 (39.7%)
 Mean nodule size (mm) 4.3 (2–5) 4.4 (3–5) 4.3 (2–5) .303
 Mean patient age (y) 47.0 (21–72) 48.3 (21–72) 45.2 (22–67) .103
 Women 111 66 45 .663
 Men 15 10 5
Note.—Unless otherwise indicated, data are numbers of nodules or patients.
* P values were calculated by using generalized estimating equation analysis.
Figure 2
Figure 2: Elastography scores according to Rago criteria. (a) A score of 1 indicated even elasticity in the whole nodule. (b) A score of 2 indicated elasticity in a 
large part of the nodule. (c) A score of 3 indicated elasticity only at the peripheral part of the nodule. (d) A score of 4 indicated no elasticity in the nodule. (e) A score 
of 5 indicated no elasticity in the nodule or in the area showing posterior shadowing.
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Figure 3
Figure 3: Elastography scores according to Asteria criteria. (a) A score of 1 indicated elasticity in the whole examined area. 
(b) A score of 2 indicated elasticity in a large part of the examined area. (c) A score of 3 indicated stiffness in a large part of the 
examined area. (d) A score of 4 indicated a nodule without elasticity.
Table 2
Grayscale US and Elastography Features according to Malignancy and Benignity
Feature No. of Malignant Nodules (n = 217) No. of Benign Nodules (n = 486) P Value*
Echogenicity ,.001†
 Hyperechogenicity (n = 3) 0 (0) 3 (100) .999
 Isoechogenicity (n = 200) 7 (3.5) 193 (96.5) ,.001
 Hypoechogenicity (n = 433) 169 (39.0) 264 (61.0) ,.001
 Marked hypoechogenicity (n = 67) 41 (61.2) 26 (30.8) ,.001
Margin ,.001
 Well defined (n = 376) 29 (13.4) 347 (71.4)
 Poorly defined (n = 327) 188 (86.6) 139 (28.6)
Calcification ,.001†
 Microcalcification (n = 106) 79 (74.5) 27 (25.5) ,.001
 Macrocalcification (n = 96) 26 (27.1) 70 (72.9) .389
 Eggshell calcification (n = 18) 2 (11.1) 16 (88.9) .020
 No calcification (n = 483) 110 (22.8) 373 (77.2) ,.001
Shape ,.001
 Wider than tall (n = 456) 69 (15.1) 387 (84.9)
 Taller than wide (n = 247) 148 (59.9) 99 (40.1)
Final assessment ,.001
 Probably benign (n = 342) 18 (5.3) 324 (94.7)
 Suspicious (n = 361) 199 (55.1) 162 (44.9)
Rago criteria ,.001
 Score 1, 2, or 3 (n = 646) 183 (28.3) 463 (71.7)
 Score 4 or 5 (n = 57) 34 (59.6) 23 (40.4)
Asteria criteria ,.001
 Score 1 or 2 (n = 358) 75 (20.9) 283 (79.1)
 Score 3 or 4 (n = 345) 142 (41.2) 203 (581.8)
Note.—Unless otherwise indicated, data are numbers of nodules, and numbers in parentheses are percentages.
* P values were calculated by using generalized estimating equation analysis.
† Fisher exact test.
for malignancy (9). The elastography 
scores were prospectively recorded 
along with the gray-scale US features 
in the radiology reports.
US-guided FNA Biopsy
US-guided FNA biopsy was performed 
by the same radiologists who performed 
gray-scale US and elastography. FNA 
was usually performed in either thyroid 
nodules with suspicious gray-scale US 
assessment or the largest thyroid nod-
ule with probably benign assessment 
when no other lesion showed suspicious 
features at US. US-guided FNA was 
performed by using a 23-gauge needle 
and a 2-mL disposable plastic syringe 
with a freehand technique.
Data Analysis
By using the indicator of malignancy as 
the dependent variable, the association 
between malignancy and patient age 
and sex for 703 nodules in 676 patients 
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were compared by using a generalized 
estimating equation analysis based on 
a binary logistic regression model. The 
correlation structure was modeled by 
assuming observations to be symmetri-
cally correlated when derived from le-
sions within the same patient and oth-
erwise independent. The final diagnosis 
was based on the cytologic and histo-
pathologic results. Gray-scale US fea-
tures and scores with Rago criteria and 
Asteria criteria showing association to 
thyroid malignancy were evaluated by 
using generalized estimating equation 
analysis. Diagnostic performances such 
as sensitivity, specificity, positive pre-
dictive value (PPV), negative predictive 
value (NPV), and accuracy of gray-scale 
US, Rago criteria, and Asteria criteria 
were compared by using generalized 
estimating equation analysis. Odds ra-
tios (ORs) with 95% confidence inter-
vals of gray-scale US, Rago criteria, and 
Asteria criteria for predicting thyroid 
malignancy were also calculated and 
compared by using generalized esti-
mating equation analysis. To investigate 
the suitable model in predicting thyroid 
malignancy, quasi–likelihood informa-
tion criterion was calculated (26). The 
smaller quasi–likelihood information 
criterion means the suitable model for 
predicting thyroid malignancy. All diag-
nostic performances of gray-scale US, 
Rago criteria, and Asteria criteria were 
compared in all nodules, in nodules 
larger than 10 mm and smaller than or 
equal to 10 mm, and in nodules larger 
than 5 mm and smaller than or equal 
to 5 mm, respectively. Because mac-
rocalcifications within the nodule may 
have effect on the stiffness and cause 
false-positive results at elastography 
(2,9–11,13,16), we also evaluated the 
diagnostic performances of 589 thyroid 
nodules in 564 patients after excluding 
114 thyroid nodules with macro- or egg-
shell calcifications in 112 patients.
To validate whether adding Rago 
criteria (13) or Asteria criteria (9) elas-
tography to gray-scale US improved the 
diagnostic performances for predicting 
thyroid malignancy, three sets of cri-
teria were assigned as follows: crite-
ria set 1, thyroid nodules with one or 
more suspicious gray-scale US features 
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Figure 4
Figure 4: Images in a 46-year-old woman who underwent routine checkup. A 10-mm right thyroid nodule 
(arrows) with marked hypoechogenicity, poorly defined margins, microcalcifications, and a taller-than-wide 
shape was found at gray-scale US and assessed as suspicious. A score of 2, with both Rago and Asteria 
criteria, was assigned at elastography. This thyroid nodule was diagnosed as papillary thyroid carcinoma at 
cytologic evaluation and as a diffuse sclerosing variant of papillary thyroid carcinoma after surgery.
Figure 5
Figure 5: Images in a 49-year-old woman who underwent routine checkup. An 8-mm left thyroid nodule 
(arrows) with hypoechogenicity, poorly margins, and taller-than-wide shape was found at gray-scale US and 
assessed as suspicious. A score of 2, with both Rago and Asteria criteria, was assigned at elastography. This 
thyroid nodule was diagnosed as papillary thyroid carcinoma at cytologic evaluation and surgery.
that were assessed as suspicious; crite-
ria set 2, Rago criteria scores of 4 or 
5 were added as one of the suspicious 
features to criteria set 1; and criteria 
set 3, Asteria criteria scores of 3 or 4 
were added as suspicious features to 
criteria set 1. We compared the sen-
sitivity, specificity, PPV, NPV, accuracy, 
ORs with 95% confidence intervals, and 
quasi–likelihood information criterion 
(26) of three criteria in 589 nodules 
with macro- and eggshell calcifications 
in 564 patients, as well as all 703 nod-
ules in all 676 patients.
The PPV and NPV were recalcu-
lated based on the Bayes theorem as 
follows: PPV = sensitivity 3 prevalence/
(specificity 3 prevalence) + ([12spec-
ificity] 3 [12prevalence]), and NPV = 
specificity (12prevalence)/(specificity 
3 [12prevalence]) + ([12sensitivity] 3 
prevalence).
Prevalence used in this equation 
was the reported prevalence of malig-
nancy in thyroid nodules selected for 
US-guided FNA in the Korean popula-
tion, 10.5% (27), which was consistent 
with the prevalence of other studies, 
9.2%–13.0% (28).
Statistical significance was deter-
mined at a P value less than .05. Sta-
tistical analyses were performed with 
statistical software (SAS system for 
Windows, version 9.1.3; SAS Institute, 
Cary, NC).
Results
Demographic and Pathologic 
Characteristics
The mean age of patients with malig-
nant nodules was younger than that 
of patients with benign nodules (P , 
.001). Sex of patients was not associ-
ated with malignancy (P = .809) (Table 
1).
Each Gray-Scale US and Elastography 
Feature Associated with Malignancy
Gray-scale US features of marked hy-
poechogenicity, poorly defined mar-
gin, microcalcifications, a shape that is 
taller than wide, and suspicious assess-
ment were more significantly seen in 
malignant nodules than benign nodules 
(all P , .001) (Table 2). Scores of 4 and 
5 with Rago criteria and scores of 3 and 
4 with Asteria criteria were also more 
significantly seen in malignant nodules 
than in benign nodules (all P , .001).
Diagnostic Performance of Gray-Scale US, 
Rago Criteria, and Asteria Criteria
In the 703 nodules in 676 patients, sen-
sitivities, NPVs, and recalculated NPVs 
of gray-scale US were significantly 
higher than those of elastography with 
Rago and Asteria criteria, regardless of 
nodule size (Table 3) (Figs 4, 5). Accu-
racy of gray-scale US was significantly 
higher than that of elastography with 
Asteria criteria except for in nodules 5 
mm or smaller. Accuracy of gray-scale 
US features was mostly higher than that 
of elastography with Rago criteria, but 
it was not statistically significant. How-
ever, the ORs of gray-scale US were 
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higher than those with Rago and Aste-
ria criteria and the quasi–likelihood in-
formation criteria of gray-scale US were 
smaller regardless of nodule size.
In the 589 nodules in 564 patients 
selected after exclusion of 114 nodules 
with macro- or eggshell calcifications in 
112 patients, sensitivities and NPVs of 
gray-scale US were significantly higher 
than those of elastography with Rago 
and Asteria criteria, regardless of nod-
ule size, with an exception of sensitiv-
ity in Asteria criteria of nodules larger 
than 10 mm (Table 4). All accuracies of 
gray-scale US were significantly higher 
than those with Rago and Asteria crite-
ria except in nodules 5 mm or smaller. 
All ORs of gray-scale US were higher 
than those with Rago and Asteria crite-
ria and all quasi–likelihood information 
criteria of gray-scale US were smaller.
In the 703 nodules, specificities, 
NPVs, accuracies, and ORs of gray-
scale US, Rago criteria, and Asteria 
criteria in nodules larger than10 mm 
or those in nodules larger than 5 mm 
were superior to those in nodules 10 
mm or smaller or 5 mm or smaller, 
respectively. In the 589 nodules with-
out macro- or eggshell calcifications, 
specificities, accuracies, and ORs of 
gray-scale US, Rago criteria, and As-
teria criteria in nodules larger than 10 
mm or those in nodules larger than 5 
mm were superior to those in nodules 
smaller than or equal to 10 mm or 5 
mm, respectively. Diagnostic perfor-
mances other than sensitivities of gray-
scale US, Rago criteria, and Asteria cri-
teria in nodules 5 mm or smaller were 
inferior to those of nodules 10 mm or 
smaller.
Diagnostic Performance of the Three Sets 
of Criteria
In the 703 nodules in 676 patients, 
specificities, PPVs, recalculated PPVs, 
and accuracies of criteria set 1 were 
significantly higher than those of crite-
ria sets 2 and 3 (Table 5). ORs of crite-
ria set 1 were equal to or higher than 
those of criteria sets 2 and 3 and the 
quasi–likelihood information criteria of 
criteria set 1 were equal to or smaller 
except for in nodules smaller than 5 
mm. Sensitivities and NPVs of criteria 
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sets 1, 2, and 3 did not show significant 
differences.
Excluding the nodules with macro- 
or eggshell calcifications, in the 589 
nodules in 564 patients, specificities, 
PPVs, recalculated PPVs, and accu-
racies of criteria set 1 were equal to or 
higher than those of criteria sets 2 and 
3 (Table 6). Specificities, PPVs, NPVs, 
and accuracies of criteria sets 2 and 3 
were not better than those of criteria 
set 1. ORs of criteria set 1 were equal 
to or higher than those of criteria sets 
2 and 3 regardless of nodule size, and 
quasi–likelihood information criteria 
of criteria set 1 were smaller than or 
equal to those of criteria sets 2 and 3.
In the 703 nodules in 676 patients, 
accuracies and ORs of the three sets of 
criteria in nodules larger than 10 mm 
or larger than 5 mm in size were higher 
than those of nodules smaller than or 
equal to 10 or 5 mm, respectively. Ac-
curacies and ORs of the three sets of 
criteria in nodules less than or equal 
to 5 mm were the smallest in value. In 
the 589 nodules without macro- or egg-
shell calcifications in 564 patients, ac-
curacies and ORs of the three criteria 
sets in thyroid nodules larger than 10 
mm or larger than 5 mm were higher 
than those in nodules smaller than or 
equal to 10 or 5 mm, respectively. The 
accuracies of the three sets of criteria 
in nodules less than or equal to 5 mm 
were the smallest.
Discussion
Elastography has been introduced to 
evaluate hardness objectively, to im-
prove the diagnostic performance of 
gray-scale US examination in differen-
tial diagnosis of thyroid nodules, and to 
eventually reduce unnecessary benign 
biopsies in thyroid nodules (2,3,5–16). 
Many previous studies have proved 
that elastography is useful in differen-
tiating malignant from benign nodules 
(2,3,7,9–16). In our study, scores of 
4 and 5 with Rago criteria and scores 
of 3 and 4 with Asteria criteria were 
more significantly seen in malignant 
nodules than benign; our findings were 
consistent with those other studies 
(2,3,7,9–16).
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Elastography is usually performed 
in thyroid nodules detected at gray-
scale US, and the high diagnostic 
performances of combinations of sus-
picious gray-scale US features are val-
idated through many previous studies 
(18–24,29–31) as well as in our study. 
Accordingly, for elastography to be 
used widely as an adjunctive diagnostic 
tool supporting gray-scale US or to be 
used as a separate diagnostic tool, sev-
eral conditions should be fulfilled. The 
diagnostic performance of elastography 
itself or a combination of elastography 
and gray-scale US should be superior 
to that of gray-scale US alone. In our 
study, sensitivities, NPVs, recalculated 
NPVs (recalculated by based on the 
Bayes theorem), and ORs of the com-
bination of suspicious gray-scale US 
features were higher than those of the 
Rago and Asteria criteria, regardless 
of nodule size and presence of macro- 
or eggshell calcifications. The quasi-
likelihood information criteria of gray-
scale US were smaller than Rago and 
Asteria criteria, which meant that the 
gray-scale US was a suitable model for 
predicting malignancy. Most diagnostic 
performances of criteria set 1 were bet-
ter than those of criteria sets 2 and 3 
and all ORs of criteria set 1 were equal 
to or superior to those of criteria sets 
2 or 3. Most of the quasi-likelihood in-
formation criteria of criteria set 1 were 
equal to or smaller than those of crite-
ria sets 2 and 3. Therefore, elastogra-
phy was not useful in predicting thyroid 
malignancy as an adjunctive diagnostic 
tool to gray-scale US or as a separate 
diagnostic tool.
Although Rago et al demonstrated 
that elastography with freehand tech-
nique shows high diagnostic perfor-
mances even in nodules smaller than 
10 mm (3), we found that specificities, 
PPVs, NPVs, accuracies, and ORs of 
both Rago and Asteria criteria in nod-
ules larger than 10 mm and larger than 
5 mm were inferior to those in nod-
ules 10 mm or smaller and 5 mm or 
smaller, respectively. Nodules 5 mm 
or smaller, specifically, accuracies and 
ORs of gray-scale US, Rago criteria, As-
teria criteria, criteria set 1, criteria set 
2, and criteria set 3 were the smallest. 
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Suspicious gray-scale US features have 
high false-positive rates in nodules 5 
mm or smaller (32). In our study, the 
false-positive rates of the three criteria 
sets were also high in nodules 5 mm 
or smaller. In nodules smaller than or 
equal to 5 mm, both gray-scale US and 
elastography have their limitations in 
predicting thyroid malignancy, although 
the clinical importance of these small 
cancers is not clear.
Our study had limitations. First, 
the reference standard was set as cy-
tologic results for 482 nodules in 474 
patients and as histopathologic results 
for 221 nodules in 202 patients, thus, 
including nodules without surgical con-
firmation. False-negative cytologic re-
sults may have existed. Second, cystic 
nodules were excluded from this study 
because elastography for cystic nodules 
does not give useful information (3). 
Third, most of 217 malignancies are 
papillary thyroid carcinomas and their 
variant form. There were no cases of 
follicular adenoma or follicular carci-
noma and subgroups of follicular neo-
plasm have not been evaluated. There 
is a debate on the role of elastography 
in differentiating malignant from be-
nign in nodules with indeterminate cy-
tology (3,10,11,13,14). Studies to ana-
lyze elastography in follicular neoplasm 
are anticipated. Fourth, US examina-
tion, US-guided FNA, and elastography 
in this study were performed by eight 
radiologists, reflecting the expected 
variation among readers that inevita-
bly exists in clinical practice. Studies 
on interobserver variability for US de-
scription and elastography at our insti-
tution have shown that US assessment 
showed a more than moderate degree 
of agreement (33) while elastography 
does not show reliable agreement (34). 
This may be due to the different US 
machines used and the fact that dif-
ferent radiologists were involved in 
obtaining elastography images. Fifth, 
this study did not focus on the diag-
nostic performances of elastography 
in subgroups such as benign nodules 
with suspicious assessment or malig-
nant nodules with probably benign as-
sessment at gray-scale US. To obtain 
more detail on the role of elastography 
regarding these subgroups, future stud-
ies are needed. Sixth, the malignancy 
rate of thyroid nodules with US-guided 
FNA was 30.9%. To compensate for 
the defect related to PPV and NPV, we 
have recalculated the PPN and NPV 
based on the Bayes theorem.
In conclusion, elastography, as well 
as the combination of elastography and 
gray-scale US, showed inferior perfor-
mance in differentiating malignant and 
benign thyroid nodules in comparison 
with gray-scale US features. Elastog-
raphy was not a useful tool in recom-
mending FNA biopsy.
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